Home » Glaxo Hyped Breast Cancer Drug, FDA Says
Glaxo Hyped Breast Cancer Drug, FDA Says
Government regulators have criticized GlaxoSmithKline for downplaying the risks of its breast cancer drug Tykerb, while exaggerating the benefits in letters to doctors.
CNN Money
CNN Money
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May